These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9447221)

  • 21. Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population.
    Happe LE; Lunacsek OE; Kruzikas DT; Marshall GS
    Pediatr Infect Dis J; 2009 Feb; 28(2):98-101. PubMed ID: 19148039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):829-30. PubMed ID: 19661857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AAFP age charts for periodic health examinations: 19 months to six years.
    Am Fam Physician; 1991 Dec; 44(6):2241-2. PubMed ID: 1746399
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of the sequential IPV/OPV schedule on vaccination coverage levels--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Dec; 47(47):1017-9. PubMed ID: 9853937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination vaccines for childhood immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP).
    Am Fam Physician; 1999 May; 59(9):2565-74. PubMed ID: 10323362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(39):1079-80. PubMed ID: 18830213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AAFP age charts for periodic health examinations: seven to 12 years. The Commission on Public Health and Scientific Affairs.
    Am Fam Physician; 1992 Jan; 45(1):267-8. PubMed ID: 1728097
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
    Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
    Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 31. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(39):1078-9. PubMed ID: 18830212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Summary of rules for childhood immunization.
    Pediatr Ann; 1998 Jul; 27(7):407-8. PubMed ID: 9677610
    [No Abstract]   [Full Text] [Related]  

  • 34. ACIP moves ahead with plans for use of IPV.
    Marwick C
    JAMA; 1995 Nov; 274(18):1417-8. PubMed ID: 7474176
    [No Abstract]   [Full Text] [Related]  

  • 35. AAFP position paper: fluoridation of public water supplies. AAFP Commission on Public Health.
    Am Fam Physician; 1996 May; 53(7):2373-7. PubMed ID: 8638512
    [No Abstract]   [Full Text] [Related]  

  • 36. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Child vaccination, part 2: childhood vaccination procedures.
    Zimmerman RK; Burns IT
    J Fam Pract; 2000 Sep; 49(9 Suppl):S34-9; quiz S40. PubMed ID: 11032191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost analysis of post-polio certification immunization policies.
    Sangrujee N; Cáceres VM; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.